US Broker Ratings

The Pennant Group, Inc. (PNTG) Stock Analysis: Healthcare Growth with a 14% Upside Potential

The Pennant Group, Inc. (NASDAQ: PNTG), a prominent player in the healthcare sector, is drawing attention from investors due to its robust growth metrics and promising analyst ratings. With a..

MannKind Corporation (MNKD) Stock Analysis: Unpacking the 137.87% Potential Upside

MannKind Corporation (MNKD) is capturing the attention of investors with a compelling investment proposition. As a prominent player in the biotechnology sector, MannKind has carved a niche in developing transformative..

Aveanna Healthcare Holdings Inc (AVAH) Investor Outlook: Analyzing a 15% Potential Upside

Aveanna Healthcare Holdings Inc (AVAH), an integral player in the U.S. healthcare sector, has captured investor interest with its robust revenue growth and a promising potential upside of 15.05%. As..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 58% Potential Upside in the Biotech Sector

Investors in the biotech sector should keep a keen eye on MiMedx Group, Inc. (NASDAQ: MDXG), a company specializing in the development and distribution of placental tissue allografts. With a..

ANI Pharmaceuticals, Inc. (ANIP)

⚠️ No article content returned.

..

Clover Health Investments (CLOV): Exploring a 24% Upside Potential with a Strong Revenue Growth Story

Clover Health Investments, Corp. (NASDAQ: CLOV) stands as a noteworthy player in the healthcare sector, specifically within the healthcare plans industry. With a strong focus on providing Medicare Advantage plans..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 66% ROE and Promising Analyst Ratings

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stands out in the biotechnology sector with its focus on developing therapies for autoimmune diseases with significant unmet needs. Headquartered in Edmonton, Canada, Aurinia’s primary..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A Promising 19.93% Upside in the Booming Mental Health Sector

Investors eyeing opportunities in the healthcare sector might find LifeStance Health Group, Inc. (NASDAQ: LFST) an intriguing candidate. With a market capitalization of $4.5 billion, LifeStance is a significant player..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Evaluating a Potential 89% Upside in Biotech Innovation

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a burgeoning name in the biotechnology sector, has been capturing attention with its innovative approach to tackling cardiorenal conditions. As a healthcare entity at the..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Exploring a 32.86% Upside Potential

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV), a leading player in the development and sale of buprenorphine-based prescription drugs, has been drawing attention from investors due to its robust growth prospects and..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector with a 2.92% Upside

Azenta, Inc. (NASDAQ: AZTA) presents a compelling opportunity for investors looking to capitalize on steady growth within the healthcare sector. Specializing in medical instruments and supplies, Azenta has carved a..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Unpacking a 12.67% Upside Potential for Investors

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, particularly in the medical care facilities industry, has captured the attention of investors with its promising growth..

agilon health, inc. (AGL) Stock Analysis: Navigating a 48.79% Upside Potential in Healthcare

Investors with a keen eye on the healthcare sector may find agilon health, inc. (NYSE: AGL) a compelling opportunity, as the company navigates the complex landscape of medical care facilities..

ImmunityBio, Inc. (IBRX) Stock Analysis: A 49.65% Potential Upside Driven by Innovative Immunotherapies

ImmunityBio, Inc. (NASDAQ: IBRX) stands at the intersection of biotechnology innovation and investor interest, with a market cap of $9.03 billion. This San Diego-based company operates within the healthcare sector,..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating the Potential Despite a -33.56% Downside Projection

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, has carved out a significant niche in the medical devices industry. Specializing in cutting-edge technology for biological system..

Apogee Therapeutics (APGE): Investor Outlook on a $10.22 Billion Biotech Pioneer

In the dynamic world of biotechnology, Apogee Therapeutics, Inc. (NASDAQ: APGE) stands out as a formidable player, with an impressive market capitalization of $10.22 billion. Based in the United States..

Ocular Therapeutix (OCUL): Investor Outlook Reveals 253.90% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing the attention of investors with its promising pipeline in the biotechnology sector. Specializing in innovative ophthalmic therapies, this Bedford, Massachusetts-based company is poised..

Envista Holdings Corporation (NVST) Stock Analysis: A 26.42% Potential Upside in the Dental Healthcare Sector

Envista Holdings Corporation (NYSE: NVST) is a key player in the healthcare sector, specializing in medical instruments and supplies, particularly in the dental industry. With a market capitalization of $3.81..

Astrana Health Inc. (ASTH) Stock Analysis: Strong Buy Ratings Signal 47% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company, is capturing investor attention with its impressive growth metrics and a strong buy consensus from analysts. Based in Alhambra, California, Astrana..

CG Oncology, Inc. (CGON) Stock Analysis: Navigating a 30.84% Potential Upside in the Biotechnology Sector

In the rapidly evolving landscape of biotechnology, CG Oncology, Inc. (NASDAQ: CGON) stands out as a noteworthy player, attracting significant attention from investors due to its promising clinical pipeline and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds